Irinotel – Irnotecan Injection
IRNOTECAN (IRINOTEL) INJECTION – TREATMENT FOR CANCER OF COLON AND RECTUM
Colon and rectum cancers are treated with Irinotel injection. By halting or reducing the growth of cancer cells, it demonstrates its effectiveness.
Irinotel Injection is administered by a licensed medical expert as an IV infusion into a vein. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
USES OF IRNOTECAN (IRINOTEL) INJECTION
- Cancer of the colon and rectum
WORKS OF IRNOTECAN (IRINOTEL) INJECTION
An anti-cancer drug is Irinotel injection. It functions by reducing the activity of an enzyme (topoisomerase I) necessary for the cancer cells’ DNA replication. As a result, cancer cells finally perish and their proliferation is slowed.
SIDE EFFECTS OF IRNOTECAN (IRINOTEL) INJECTION
- Hair loss
- Anemia (low number of red blood cells)
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
WARNING & PRECAUTIONS
Irinotel Injection may make you feel sleepy and woozy, less attentive, or have an impact on your vision. If you experience these symptoms, don’t drive.
It is dangerous to use Irinotel injection during pregnancy because there is clear evidence that it poses a risk to the unborn child. However, if the advantages outweigh the possible risks, a doctor might very rarely recommend it in specific life-threatening circumstances. Please speak with your physician.
Fedelty Health Care is an Irnotecan third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.